Time to treatment influences the impact of ST-segment resolution on one-year prognosis: Insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Trial

Circulation

Volumn 104, Issue 22, 2001, Pages 2653-2659

  Fu, Yuling ^a   Goodman, Shaun ^b   Chang, Wei Ching ^a   Van De Werf, Frans ^c   Granger, Christopher B ^d   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Fibrinolysis; Myocardial infarction; Reperfusion

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; RISK ASSESSMENT; ST SEGMENT ELEVATION;

EID: 0035960606     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4701.099731     Document Type: Article

References (28)

1. ST segment resolution and infarct-related artery patency and flow after thrombolytic therapy
2. Early assessment of outcome by ST-segment analysis after thrombolytic therapy in acute myocardial infarction
3. Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction
4. Extent of early ST-segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) Trial
5. Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction
6. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent: A GISSI2-derived analysis
7. Single bolus tenecteplase compared with frontloaded alteplase in acute myocardial infarction: The ASSENT 2 double blind randomized trial
8. Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction
9. The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction
10. Impaired myocardial tissue perfusion early after successful thrombolysis: Impact on myocardial flow, metabolism and function at late follow-up
11. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction
12. Prognostic value of slow resolution of ST segment elevation following successful direct percutaneous transluminal coronary angioplasty for recovery of left ventricular function
13. Determinants and prognostic implications of persistent ST segment elevation after primary angioplasty for acute myocardial infarction: Importance of microvascular reperfusion injury on clinical outcome
14. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA
15. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis
16. Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): Results of the Israeli Study of Early Intervention in Myocardial Infarction
17. Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function
18. The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion
19. Early recurrence of ST segment elevation in patients with initial reperfusion during thrombolytic therapy: Impact on in-hospital reinfarction and long-term vessel patency
20. Noninvasive assessment of speed and stability of infarct-related artery reperfusion
21. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: The GUSTO-I ST Segment Monitoring Substudy
22. Intermittent coronary occlusion in acute myocardial infarction: Value of combined thrombolytic and vasodilator therapy
23. Noninvasive detection of coronary artery patency using continuous ST-segment monitoring
24. Reperfusion in acute myocardial infarction: Effect of timing and modulating factors in experimental models
25. Assessment of "Microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction
26. Relation between symptom duration before thrombolytic therapy and final myocardial infarct size
27. Abciximab improves both epicardial flow and myocardial reperfusion in ST elevation myocardial infarction: Observations from the TIMI 14 trial
28. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction